Hangzhou Aobo Pharmaceutical

Hangzhou Aobo Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-end chemical drugs and active pharmaceutical ingredients (APIs). Founded in 2010 and headquartered in Hangzhou, the company focuses on therapeutic areas such as cardiovascular diseases, oncology, and metabolic disorders. Aobo is particularly recognized for its robust portfolio of antithrombotic agents, including major products like Rivaroxaban and Apixaban. The company operates integrated R&D centers and GMP-compliant manufacturing facilities, supporting both its generic drug business and its pipeline of innovative small molecule candidates. With a strong emphasis on quality and technological innovation, Hangzhou Aobo Pharmaceutical serves both domestic and international markets.